Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease

Mise à jour : Il y a 5 ans
Référence : NCT00195715

Femme et Homme

Extrait

To evaluate the long-term maintenance of response, safety and tolerability of repeated administration of adalimumab in subjects with Crohn's disease who participated in and successfully completed Protocol M02-404 or Protocol M04-691.


Critère d'inclusion

  • Crohn’s Disease


Liens